2021
DOI: 10.36660/abc.20200172
|View full text |Cite
|
Sign up to set email alerts
|

A Molécula de Lesão Renal-1 está Associada à Nefropatia Induzida por Contraste em Pacientes Idosos com IAMSSST

Abstract: Fundamento: A nefropatia induzida por contraste (NIC) está associada a um risco aumentado de eventos cardiovasculares adversos maiores (ECAM), e a associação entre NIC e mecanismos oxidativos está bem documentada. Objetivo: Este estudo visou avaliar a relação entre os níveis séricos da molécula de lesão renal-1 (KIM-1) e a NIC em pacientes idosos com infarto do miocárdio sem supradesnivelamento do segmento ST (IAMSSST). Métodos: O presente estudo incluiu um total de 758 pacientes com IAMSSST que foram submetid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
0
0
0
Order By: Relevance
“…The indiscriminate use of Iodinated Contrast (IC) means in coronary interventions contributes to the third cause of in-hospital acute kidney injury (AKI); contrast-induced nephropathy (CIN), which has an incidence of 2% in the general population and 40% in the population with risk factors (1)(2)(3)(4). CIN is defined by the KDIGO criteria as an increase in serum creatinine of 0.5 mg/dl (44mmol/l) or an increase of 25% in relation to the baseline value, evaluated within 48 hours after contrast administration (5).…”
Section: Introductionmentioning
confidence: 99%
“…The indiscriminate use of Iodinated Contrast (IC) means in coronary interventions contributes to the third cause of in-hospital acute kidney injury (AKI); contrast-induced nephropathy (CIN), which has an incidence of 2% in the general population and 40% in the population with risk factors (1)(2)(3)(4). CIN is defined by the KDIGO criteria as an increase in serum creatinine of 0.5 mg/dl (44mmol/l) or an increase of 25% in relation to the baseline value, evaluated within 48 hours after contrast administration (5).…”
Section: Introductionmentioning
confidence: 99%